159 related articles for article (PubMed ID: 38811157)
1.
Amaeze O; Isoherranen N; Shum S
Drug Metab Dispos; 2024 May; ():. PubMed ID: 38811157
[TBL] [Abstract][Full Text] [Related]
2. Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA-Based Therapeutics Using a Mechanistic Physiologically-Based Pharmacokinetic-Pharmacodynamic Model.
Lumen A; Zhang X; Dutta S; Upreti VV
Clin Pharmacol Ther; 2024 May; 115(5):1054-1064. PubMed ID: 38282246
[TBL] [Abstract][Full Text] [Related]
3. Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitations.
Berezowska M; Sharma P; Pilla Reddy V; Coppola P
Fundam Clin Pharmacol; 2024 Jun; 38(3):402-409. PubMed ID: 37968879
[TBL] [Abstract][Full Text] [Related]
4. Development and Verification of a Linked
Patilea-Vrana GI; Unadkat JD
Drug Metab Dispos; 2021 Jul; 49(7):509-520. PubMed ID: 33952608
[TBL] [Abstract][Full Text] [Related]
5. A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome.
van Hoogdalem MW; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
Pharmacol Ther; 2022 Jun; 234():108045. PubMed ID: 34813863
[TBL] [Abstract][Full Text] [Related]
6. Predicting Maternal-Fetal Disposition of Fentanyl Following Intravenous and Epidural Administration Using Physiologically Based Pharmacokinetic Modeling.
Shum S; Shen DD; Isoherranen N
Drug Metab Dispos; 2021 Nov; 49(11):1003-1015. PubMed ID: 34407992
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and Pharmacodynamic Modeling of siRNA Therapeutics - a Minireview.
Jeon JY; Ayyar VS; Mitra A
Pharm Res; 2022 Aug; 39(8):1749-1759. PubMed ID: 35819583
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Pharmacodynamics of GalNAc-Conjugated siRNAs.
An G
J Clin Pharmacol; 2024 Jan; 64(1):45-57. PubMed ID: 37589246
[TBL] [Abstract][Full Text] [Related]
9. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
[TBL] [Abstract][Full Text] [Related]
10. Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populations.
Jogiraju VK; Avvari S; Gollen R; Taft DR
Biopharm Drug Dispos; 2017 Oct; 38(7):426-438. PubMed ID: 28474821
[TBL] [Abstract][Full Text] [Related]
11. Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.
De Sousa Mendes M; Hirt D; Urien S; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Benaboud S
Br J Clin Pharmacol; 2015 Nov; 80(5):1031-41. PubMed ID: 26011128
[TBL] [Abstract][Full Text] [Related]
12. The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of
McDougall R; Ramsden D; Agarwal S; Agarwal S; Aluri K; Arciprete M; Brown C; Castellanos-Rizaldos E; Charisse K; Chong S; Cichocki J; Fitzgerald K; Goel V; Gu Y; Guenther D; Habtemariam B; Jadhav V; Janas M; Jayaraman M; Kurz J; Li J; Liu J; Liu X; Liou S; Maclauchlin C; Maier M; Manoharan M; Nair JK; Robbie G; Schmidt K; Smith P; Theile C; Vaishnaw A; Waldron S; Xu Y; Zhang X; Zlatev I; Wu JT
Drug Metab Dispos; 2022 Jun; 50(6):781-797. PubMed ID: 34154993
[TBL] [Abstract][Full Text] [Related]
13. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition.
Poulin P; Theil FP
J Pharm Sci; 2002 May; 91(5):1358-70. PubMed ID: 11977112
[TBL] [Abstract][Full Text] [Related]
14. Physiologically Based Pharmacokinetic Modelling for Nicotine and Cotinine Clearance in Pregnant Women.
Amice B; Ho H; Zhang E; Bullen C
Front Pharmacol; 2021; 12():688597. PubMed ID: 34354586
[No Abstract] [Full Text] [Related]
15. Physiologically-Based Pharmacokinetic Modeling of Tenofovir Disoproxil Fumarate in Pregnant Women.
Zhang X; Luo T; Yang H; Ma WY; He Q; Xu M; Yang Y
Curr Drug Metab; 2023; 23(14):1115-1123. PubMed ID: 36718061
[TBL] [Abstract][Full Text] [Related]
16. Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after delivery.
Dallmann A; Himstedt A; Solodenko J; Ince I; Hempel G; Eissing T
J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):341-359. PubMed ID: 32748112
[TBL] [Abstract][Full Text] [Related]
17. Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of
Ayyar VS; Song D; Zheng S; Carpenter T; Heald DL
J Pharmacol Exp Ther; 2021 Nov; 379(2):134-146. PubMed ID: 34413198
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
[TBL] [Abstract][Full Text] [Related]
19.
Isoherranen N
Drug Metab Dispos; 2024 Feb; ():. PubMed ID: 38326033
[TBL] [Abstract][Full Text] [Related]
20. An Application of a Physiologically Based Pharmacokinetic Approach to Predict Ceftazidime Pharmacokinetics in a Pregnant Population.
Abduljalil K; Gardner I; Jamei M
Pharmaceutics; 2024 Mar; 16(4):. PubMed ID: 38675135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
